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Development of Osteogenic Cell Sheets
for Bone Tissue Engineering Applications
AU1c Roge´rio P. Pirraco,1–3 Haruko Obokata,1,4 Takanori Iwata,1 Alexandra P. Marques,2,3
Satoshi Tsuneda,4 Masayuki Yamato,1 Rui L. Reis,2,3 and Teruo Okano1
The use of scaffolds in combination with osteogenic cells has been the gold standard in bone tissue engineering
strategies. These strategies have, however, in many cases failed to produce the desired results due to issues such
as the immunogenicity of the biomaterials used and cell necrosis at the bulk of the scaffold related to deficient
oxygen and nutrients diffusion. Here, we originally propose the use of cell sheet (CS) engineering as a possible
way to overcome some of these obstacles. Osteogenic CSs were fabricated by culturing rat bone marrow stromal
cells in thermoresponsive culture dishes. The CSs were recovered from the dishes using a low-temperature
treatment and then were implanted subcutaneously in nude mice. New bone formation was verified from day 7
post-transplantation using X-ray, microcomputed tomography, and histological analysis. The presence of a
vascularized marrow was also verified in the newly formed bone after 6 weeks of transplantation. Further,
osteocytes were found in this newly formed tissue, supporting the conclusion that mature bone was formed after
ectopically transplanting osteogenic CSs. These results therefore confirm the great potentiality of CS engineering
to be used in bone tissue engineering applications.
Introduction
The number of people who require medical interventionto solve bone-related illnesses such as nonunion frac-
tures or loss of bone tissue caused by cancer tends to grow as
a result of the constant aging of population.1–3 Currently, the
gold-standard strategies to address issues like critical bone
defects involve the use of autologous bone graft, allografts,
and materials like ceramics and metals.1,3,4 All of these
strategies have significant problems (e.g., scarce availability
of tissues, donor-site morbidity issues, immunogenicity
problems, and lack of integration in the host tissue) that limit
their application range and their overall performance.1,5 It
has been accepted for a few years that new strategies are
needed to address the challenges posed in this field. Tissue
engineering (TE)-based strategies have been trying to solve
many of the above-referred problems. These approaches
typically involve the use of different cell types suitable for
bone TE, growth factors, and 3D biodegradable scaffolds.4,6
Such approaches, however, face in many cases serious
problems such as inadequate biodegradability rate and the
lack of vascularization, which leads to cell necrosis in the
bulk of the construct.2,7–10
Cell sheet (CS) engineering technique using thermo-
responsive dishes might constitute a useful alternative to
solve some of the mentioned issues. This technique, as pro-
posed by Professor Okano’s group, allows for the recovery of
the cells within its own matrix to be used as intact single, or
multilayered, CSs to engineer transplantable tissues.11–13 So
far this technology was proposed for the treatment of several
tissues such as cornea,14 myocardium,15 periodontal liga-
ment,16 and bladder,17 but never for bone. The peculiar
mechanical and biological properties of bone tissue make the
translation of the obtained outcomes from the regeneration
of the above-mentioned tissues into bone, rather compli-
cated. Others have previously attempted to produce CSs for
the regeneration of bone tissue.18–20 Zhou et al.20 wrapped
osteogenic CSs made form porcine bone marrow stromal
cells around polycaprolactone–calcium phosphate scaffolds.
The postsubcutaneous implantation analysis of the construct
showed some degree of new bone formation but mainly at
the periphery of the scaffolds. The same pattern, around the
scaffold, of new calcified tissue was achieved by Gao et al.19
using a coral scaffold, and by Akahane et al.18 using a hy-
droxyapatite ceramic scaffold. In the latter case,18 the CSs
were also ectopically implanted without any scaffold, and
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new bone formation, though disorganized, was verified. The
common outcomes of those three approaches were the for-
mation of new bone tissue fairly disorganized, poorly vas-
cularized, and limited to the surface of the scaffolds on
where the CSs were wrapped. In contrast with the above-
referred works, where cells were detached using a cell scra-
per, the use of thermoresponsive dishes allows for the use of
an intact cell–cell and cell–matrix architecture, due to the
well-developed culture dish recovery method.12,13
In this work, we aimed at studying the in vivo bone for-
mation potential of osteogenic CSs noninvasively recovered
by temperature decrease. Osteogenic CSs were created from
rat bone marrow stromal cells, cultured in thermoresponsive
dishes, and then characterized. The developed sheets were
subsequently transplanted subcutaneously to the dorsal flap
of nude mice. Implants were recovered at different time
points post-transplantation and characterized. New bone
formation was apparent from 7 days postimplantation. Six
weeks after implantation thick, newly vascularized bone
with what appears to be bone marrow was clearly observed.
Materials and Methods
Temperature-responsive culture surfaces
Thermoresponsive dishes (CellSeed) were prepared as
previously described21 Briefly, N-isopropylacrylamide
monomer in 2-propanol solution was spread onto 35-mm-
diameter culture dishes (BD Biosciences). Dishes were then
irradiated by electron beam, resulting in both polymerization
and covalent grafting of the poly(N-isopropylacrylamide)
(PIPAAm) onto the cell culture surfaces. PIPAAm-grafted
dishes were rinsed with cold-distilled water to remove un-
grafted monomer, and dried in nitrogen gas. Dishes were
finally sterilized with ethylene oxide gas before experimental
use.
CS fabrication
Bone marrow was flushed from the femurs of 4-week-old
male Wistar rats (Charles River Japan). After vigorous pi-
petting to disaggregate any clumps, the suspension
was placed over Histopaque 1083 (Sigma-Aldrich) and
centrifuged at 2500 rpm for 25min. The mononuclear cell
fraction was recovered after centrifugation and washed in
phosphate-buffered saline (Sigma-Aldrich) to remove any
remaining Histopaque. Cells were then seeded in 100-mm-
diameter tissue culture polystyrene dishes and cultured in
basal medium (AU2c low-glucose DMEM; Wako Pure Chemical
Industries), supplemented with 10% fetal bovine serum
( Japan Bioserum Co. Ltd.) and 100 units/mL of penicillin–
streptomycin (Sigma-Aldrich Japan) at 37C and in a 5% of
CO2 humidified atmosphere. After 24 h of culture, non-
adherent cells were removed from the culture and the ad-
herent cells were then cultured until semiconfluence was
achieved. Cells were detached using a 0.25% trypsin–EDTA
solution (Gibco BRL LifeTechnologies) and seeded in
35mm of diameter thermoresponsive dishes at a concentra-
tion of 2.5 · 105 cells per dish. Cultures were maintained for 3
weeks in the osteogenic medium (basal medium supple-
mented with 10 - 8 M dexamethasone [Sigma-Aldrich],
50 mg/mL ascorbic acid [Sigma-Aldrich], and 10mM b-
glycerophosphate [Sigma-Aldrich]).
Recovery of cells from thermoresponsive dishes
To recover the cells from the thermoresponsive dishes, the
culture medium was removed from the culture dishes and
replaced with 1mL of phosphate-buffered saline. A
poly(vinylidene difluoride) (PVDF) (Immobilon-P, DUR-
APORE; Millipore Corporation) membrane with a diameter
of 20 cm was placed over the cells in the thermoresponsive
dishes and incubated at 20C for 10min. After this time, CSs
spontaneously detached from thermoresponsive dishes.
Some of the recovered CSs were fixed in 10% formalin (Wako
Pure Chemicals) for posterior histological characterization.
In vivo transplantation
The transplantation of the CSs was carried out as reported
previously.22 Briefly, 6-week-old male nude mice (Charles
River Japan) (six animals per transplantation time) were
anesthetized with a constant flux of 4% of isofluorane. Dorsal
skin was cut opened using 3 · 3 cm cutting sides. Recovered
CSs were placed on mouse subcutaneous dorsal flap and left
to adhere to the connective tissue of dorsal skin for 5min.
After that time, the PVDF membranes were peeled off from
the adhered CSs and silicone membranes were placed over
the CSs to prevent the contact between the CSs and the
muscular tissue. Control mice (three animals per transplan-
tation time) were also prepared by implanting only silicone
membranes. Skin incisions were closed using 5-0 nylon su-
tures. Animals were kept with food and water ad libitum.
After 7 days, 3 weeks and 6 weeks of transplantation, ani-
mals were euthanized with CO2 and implants were recov-
ered for histological characterization.
Histological characterization
After fixation, both in vitro recovered CS and implanted
samples were embedded in paraffin, without demineral-
ization, and 5-mm-thick sections were made. Hematoxylin
and eosin staining was performed following standard pro-
tocols.
To assess mineral deposition alizarin red staining was
performed. Briefly, a solution of 0.1% of alizarin red
(Sigma-Aldrich) was made in ddH2O and the pH was ad-
justed to 4.6. Sections were deparaffinized and 1mL of
alizarin red solution was added to each slide. Sections were
observed in the microscope until correct amount of color
developed. Following that, slides were dipped three times
in hematoxylin, washed thoroughly in water, de-hydrated,
washed in xylene, and mounted with the mounting me-
dium. Pink/purple color was considered positive for min-
eral deposition. Micrographs of the sections were taken
after both stainings.
Immunostaining for osteocalcin was performed by incu-
bating both the CS after in vitro culture and the implant
sections with a 1/200 anti-osteocalcin antibody (Millipore
Corporation) overnight, at 4C, and then for 1 h, room tem-
perature, with a biotinylated secondary antibody (Dako
Cytomation). Sections were incubated with streptavidin-
horseradish peroxidase (DakoCytomation) solution for
20min and then treated with bAU2DAB chromogenic substrate
solution (DakoCytomation) for 3min.
Stained sections were analyzed with an Eclipse E800 mi-
croscope (Nikon).
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Microcomputed tomography
To investigate the 3D structure of the mineralized tissue
formed after transplantation, nondestructive techniques,
X-ray and microcomputed tomography (m-CT) (SkyScan),
were used. Recovered implants, after paraffin embedding,
were cut in half and scanned in a high-resolution mode of
11.32 mm x/y/z and an exposure time of 1900ms. The energy
of the scanner used was 50 keV with a 171 mA current. The
m-CT scans were followed by a 3D reconstruction of serial
images and quantification of the mineralized tissue using a
minimum threshold value of 70.
Calcium quantification
The samples analyzed by m-CT were used for calcium
quantification. Therefore, the halves of the recovered im-
plants were weighted and incubated in HCl 0.5M to remove
and dissolve the calcium. Calcium quantification in the ob-
tained solutions was performed using the o-cresolphtalein-
complexon method with the Roche Cobas kit (Roche
Diagnostics) following manufacturer’s instructions. The ab-
sorbance of the samples was read at 570 nm in a microplate
reader Synergy-HT (Bio-Tek). The calcium concentrations
were extrapolated from the calibration curve obtained using
serial dilutions of a calcium chloride solution and then nor-
malized using the initial tissue mass.
Statistical analysis
Data were obtained from three separate experiments with
three replicates for each condition and averaged. Standard
deviation is reported as a measure of sample deviation.
Statistical analysis of the calcium quantification and volume
of mineralized tissue was performed using Student’s t-test




The herein used CS engineering methodology allowed
fabricating and recovering intact rat bone marrow-derived
CSs composed by a dense collagenous matrix where cells are
embedded (F1c Fig. 1A). By the same micrograph observations,
the estimated thickness of the CSs after recovery was of
about 30mm (Fig. 1A).
Alizarin red staining was used to confirm the presence of
calcium deposition and matrix mineralization in the cultured
CSs (Fig. 1B). Significant calcium deposition in the cultured
CSs was observed as evidenced by the intensity of the
staining. Immunohistochemistry against osteocalcin showed
high positivity for this protein especially in the CS matrix
(Fig. 1C), confirming the osteogenic nature of the cultured
and recovered CSs after temperature decrease.
In vivo bone formation after CS transplantation
Evidences of in vivo new bone formation after transplan-
tation of the osteogenic CSs were confirmed by X-ray and
m-CT analysis (F2c Fig. 2). After 7 days of transplantation the
amount of dense tissue was already significant and a noto-
rious increase in the density of the neo-bone was observed as
the transplantation time increases.
FIG. 1. In vitro cultured cell sheets after low-temperature
recovery from thermoresponsive dishes characterized using
(A) hematoxylin and eosin staining, (B) alizarin red staining
(mineral deposition in purple), and (C) immunocytochemis-
try for osteocalcin (expression in brown). Asterisks mark the
basal side of the cell sheets. Color images available online at
www.liebertonline.com/ten.
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FIG. 2. Representative X-ray
(A, D, G) and microcomputed
tomography images (side [C,
F, I] and front view [B, E, H])
of the transplants (each di-
vided in half after recovery)
after (A–C) 7 days, (D–F) 3
weeks, and (G–I) 6 weeks of
implantation. Bars in the X-ray
images represent 2mm and
are valid for all the images.
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m-CT analysis was also employed to quantify the volume of
the mineralized new tissue (F3c Fig. 3). Results showed an incre-
ment in volume from*1mm3 for day 7 of implantation to 2.7
for the 6thweek of implantation. This evolution in the quantity
of new mineralized tissue was confirmed by calcium quanti-
fication (Fig. 3) using the o-cresolphtalein-complexon method.
The detected amount of calcium per mg of tissue increased
from 0.005mg to 0.0157mg and finally to 0.037mg, respec-
tively, at 7 days, 3 weeks, and 6 weeks postimplantation.
Alizarin red/hematoxylin and eosin staining of the in vivo
samples allowed to observe mineralized tissue at the implant
site just 7 days post-transplantation (F4c Fig. 4A). The amount of
new bone mineralized increased throughout the time of
transplantation until it reached a maximum at 6 weeks post-
transplantation (Fig. 4A–D). The new bone developed in
what appears to be separated patches along the width of the
subcutaneous dorsal flap. Six weeks after transplantation,
numerous contiguous bone patches, with a maximum
thickness of 250 mm and a maximum width of 1mm (Fig. 4C),
were clearly observed. The patches contained a cellular
marrow where numerous cells could be found, among which
red blood cells (Fig. 4D). A detailed observation (Fig. 4E)
permitted to identify osteocytes embedded in the sectioned
mineralized tissue. Moreover, osteoid deposition was evi-
dent in some of the sections analyzed (Fig. 4F).
The immunohistochemistry results for osteocalcin showed
that this protein was expressed at different locations even
after only 7 days of transplantation (F5c Fig. 5A). These positive
sites seem to correlate to sites where new bone was being
formed. With the increase of new bone formed with the
transplantation time, it was clear that the majority of the cells
that were positive for this protein were concentrated around
the new tissue (Figs. 5B, C).
Discussion
The obtained CSs had the expected characteristics after
osteogenic differentiation: collagen-rich, thick ECM with
abounding mineralized areas. After exposure to a tempera-
ture below the lower critical solution temperature, the sheets
slightly contracted, as described for other CSs,23 due to
contractile cytoskeleton forces. This means that the thickness
of the CSs after detachment, as determined by histological
analysis, was greater than when cells were attached, either to
the surface or to the PVDF membrane. The presence of what
appeared to be mineral deposits was clearly macroscopically
identified in the sheets before its recovery from the thermo-
responsive dishes. In fact, after the recovery of the CSs from
the dishes, several mineral nodules were attached to the dish
(data not shown), which was expected to happen considering
the protocol used for the osteogenic differentiation. Further,
osteocalcin, a noncollagenous matrix protein whose secretion
correlates with matrix mineralization being therefore a
marker for the osteogenic phenotype,24–26 was detected in
high amount confirming the osteogenic nature of the devel-
oped CSs (Fig. 1B).
The transplantation of the fabricated CSs to the dorsal flap
of nude mice resulted in the formation of bone mineralized
tissue, whose volume greatly increased with time. These
results also correlated with the amount of calcium quantified
at each time point and with the strong staining for osteo-
calcin, which is an expected outcome because this protein is
directly related to matrix mineralization and consequently to
new bone formation.24–26
Histology results suggest that newly formed tissue orga-
nized in patches throughout the flap. By crossing theses re-
sults with the m-CT 3D reconstruction, we could conclude
that the observed patches were ramifications of the same
bone mass. These bone masses had a flat form that may
result from the original form of the CSs and/or from the local
mechanical environment present in the mouse’s subcutane-
ous site of transplantation, which determined the form of the
new tissue.27,28
Osteoid formation was also visible in the in vivo histology
results. As demonstrated before,29 ectopic bone formation by
transplanted osteogenic cells is initiated by the deposition of
osteoid. Osteoid is a partially mineralized immature bone
that is eventually fully mineralized by osteogenic cells, thus
becoming mature bone. Histological analysis demonstrated
the presence of this immature bone proving that bone for-
mation induced by the osteogenic CSs followed the accepted
path of ectopic bone formation.29 Moreover, the newly
FIG. 3. Amount of calcium, quantified
by the o-cresolphtaleine-complexone
method (bars), and volume of mineralized
tissue measured by microcomputed to-
mography (line), of the retrieved samples
at different times postimplantation.
*p< 0.05 relating to 7 days’ values and
xp< 0.05 relating to 3 weeks’ values for
both Ca2 + quantification and mineralized
tissue volume.
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formed tissue presented a marrow space where multiple cells
were observed. Erythrocytes were detected in that marrow,
which might indicate the existence of erythropoiesis or the
vascularization of that tissue. These observations and in
particular the proven existence of a direct connection be-
tween vasculature and bone remodeling30–34 reinforce the
hypothesis that the newly formed bone was being re-
modeled. Also very important to notice was the presence of
osteocytes since, besides being the most common cells in
bone tissue, these cells are believed to be the main regulators
of bone homeostasis.35–37
Common approaches in bone TE include the use of oste-
oblasts or stem cell-derived osteoblasts, a scaffold as a 3D
matrix, and growth factors.1,4,5 Scaffolds intend to support
cell attachment and growth, and matrix production besides
supplying mechanical resistance, considered extremely im-
portant for bone regeneration applications.1,4,5 Its use pres-
ents, however, problems related to cell migration to the
interior of the scaffold as well as oxygen and nutrient dif-
fusion limitations,7–10 impairing such strategies to achieve
more successful outcomes. The gold standard in clinical
settings continues to be the autologous bone grafts.4,5 This
technique causes nonetheless severe donor-site morbidity4,5
and allogenic or xenogenic grafts have even more obvious
limitations.4,5 CS engineering is a technique that if applied to
bone regeneration can overcome many of the current limi-
tations of those approaches.
Previous works that used osteogenic CSs in in vivo set-
tings,18–20 either with or without scaffolds, have successfully
induced the formation of new bone tissue. However, the
newly formed tissue was in most cases either disorganized18
or incapable of growing in the interior of the scaffold19,20 due
to the already described scaffold limitations. CS engineering
avoids all of these shortcomings although, the lack of me-
chanical properties or the time span needed for the formation
of an adequate bone volume might be considered as limita-
tive. The most obvious application for osteogenic CSs would
be flat bone defects such as cranial defects. The shape of the
FIG. 4. Alizarin red and
hematoxylin staining of the
transplants sections recovered
after (A) 7 days, (B) 3 weeks,
and (C–F) 6 weeks of
implantation. (D) and (E) are
sequential close-ups of image
(C). Yellow arrowheads in
(E) mark osteocytes and red
arrowheads in (F) mark
osteoid deposition. Mineral
deposition is in purple. Color
images available online at
www.liebertonline.com/ten.
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CSs and the possibility of stacking several sheets, as shown
for other tissues,38,39 would allow a fast transplantation to
such a defect. Further, the mechanical requirements of flat
bones are less demanding than that of long bones,40 which
avoids one of the possible limitation of CS engineering for
bone regeneration. Nevertheless, in a recent article41 re-
serchers applied a CS recovered by cell scraper in a rat
nonunion model by wrapping the sheet around the defect.
This resulted in the regeneration of the defect in opposition
to the group without CS. This work presents a possible way
by which CSs can be applied to the regeneration of long
bones. In this case the CSs were recovered using a cell
scraper, and although cell–cell junctions are preserved using
this method, the use of thermoresponsive dishes guarantees
that both cell–matrix junctions and the ECM itself are pre-
served.12,13 The ECM can then act as natural glue that en-
ables these sheets to be applied virtually in any anatomic site
when implanted. Maeda et al.42 recently developed a device
that allows a minimally invasive endoscopic transplantation
of CSs fabricated in thermoresponsive dishes. Further de-
velopments of this method coupled with the attachment
potential of the ECM open the way to deliver CSs, using a
minimally invasive surgery, as de facto sheets for many ap-
plications, in opposition to the hypothesis of just injecting
them, as suggested by other.18,41 Also, adequate bone vol-
ume can potentially be created by methods such as the
overlay of several CSs combined with polysurgery,38 creat-
ing thicker and bigger bone tissue. This specific issue will be
addressed in future studies.
Conclusions
As already demonstrated for other tissues, CS engineering
is also a very promising technique for bone TE applications.
This work demonstrated that new bone tissue, with very
interesting characteristics, namely, the presence of osteo-
cytes, vascularization, and bone marrow formation, was
formed from a single osteogenic CS. Three-dimensional neo-
bone tissue was obtained in vivo without the use of any
biodegradable scaffold and a new window of opportunity
with great potential is open in the bone TE field.
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